| [1] |
Poonyakanok V, Warnnissorn M, Chaopotong P. Oncological outcomes and risk factors for recurrence of mucinous borderline ovarian tumors: a 15-year experience at a tertiary center[J]. J Obstet Gynaecol Res, 2024, 50(11): 2081-2092. DOI： 10.1111/jog.16085.
|
| [2] |
Wang D, Jia S, Jia C, et al. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: results of a large retrospective study[J]. Gynecol Oncol, 2022, 165(3): 446-452. DOI： 10.1016/j.ygyno.2022.04.002.
|
| [3] |
Kim SR, Madariaga A, Hogen L, et al. Safety of fertility sparing management in invasive mucinous ovarian carcinoma[J]. Gynecol Oncol, 2023, 174(7): 129-132. DOI： 10.1016/j.ygyno.2023.05.003.
|
| [4] |
Miyamoto E, Suzuki H, Yoshihara M, et al. The prognostic impact of limited-staging surgery in patients with stage ⅠA epithelial ovarian cancer: a multi-center study with a propensity score-adjusted analysis[J]. Jpn J Clin Oncol, 2023, 53(8): 698-703. DOI： 10.1093/jjco/hyad039.
|
| [5] |
Westermann T, Karabeg E, Heitz F, et al. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary[J]. Int J Gynecol Cancer, 2024, 34(6): 898-905. DOI： 10.1136/ijgc-2023-005214.
|
| [6] |
Guo L, Kang X, Su Y, et al. Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: a retrospective study[J]. Eur J Obstet Gynecol Reprod Biol, 2024, 296(5): 107-113. DOI： 10.1016/j.ejogrb.2024.02.027.
|
| [7] |
Algera M D, Van De Vijver K K, Van Driel W J, et al. Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes[J]. Int J Gynecol Cancer, 2024, 34(5): 722-729. DOI： 10.1136/ijgc-2023-004955.
|
| [8] |
Li J, Qiao H, Liu Y, et al. Safety of fertility-sparing surgery in young women with stage Ⅰ endometrioid epithelial and mucinous ovarian cancer: a population-based analysis[J]. Eur J Surg Oncol, 2024, 50(1): 107276. DOI： 10.1016/j.ejso.2023.107276.
|
| [9] |
Morice P, Scambia G, Abu-Rustum NR, et al. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE[J]. Lancet Oncol, 2024, 25(11): e602-e610. DOI： 10.1016/s1470-2045(24)00262-6.
|
| [10] |
Ikeda Y, Yoshihara M, Yoshikawa N, et al. Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study[J]. Int J Gynaecol Obstet, 2022, 157(2): 437-443. DOI： 10.1002/ijgo.13844.
|
| [11] |
Zhao J, Wang D, Wang R, et al. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study[J]. J Ovarian Res, 2024, 17(1): 96. DOI： 10.1186/s13048-024-01409-0.
|
| [12] |
Ricotta G, Maulard A, Candiani M, et al. Endometrioid borderline ovarian tumor: clinical characteristics, prognosis, and managements[J]. Ann Surg Oncol, 2022, 29(9): 5894-5903. DOI： 10.1245/s10434-022-11893-7.
|
| [13] |
|
| [14] |
Kuji S, Harada M, Yoshioka N, et al. Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: results of a retrospective nationwide study[J]. J Obstet Gynaecol Res, 2022, 48(3): 806-816. DOI： 10.1111/jog.15131.
|
| [15] |
Wang L, Zhong Q, Tang Q, et al. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors[J]. Arch Gynecol Obstet, 2022, 306(4): 1177-1183. DOI： 10.1007/s00404-022-06431-5.
|
| [16] |
Johansen G, Dahm-Kähler P, Staf C, et al. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study[J]. Fertil Steril, 2021, 115(1): 157-163. DOI： 10.1016/j.fertnstert.2020.07.043.
|
| [17] |
|
| [18] |
Sobiczewski P, Piatek S, Michalski W, et al. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: a single center experience[J]. Eur J Obstet Gynecol Reprod Biol, 2022, 269(2): 126-131. DOI： 10.1016/j.ejogrb.2021.12.029.
|
| [19] |
Song BB, Anderson ZS, Masjedi AD, et al. Fertility-sparing surgery for stage Ⅰ epithelial ovarian cancer[J]. Obstet Gynecol, 2024, 144(1): 68-78. DOI： 10.1097/aog.0000000000005530.
|
| [20] |
Jorgensen K, Denham C, Kanbergs A, et al. All-cause and cancer-specific mortality after fertility-sparing surgery for stage ⅠA and ⅠC epithelial ovarian cancer[J]. Gynecol Oncol, 2023, 178(11): 60-68. DOI： 10.1016/j.ygyno.2023.09.015.
|
| [21] |
Imterat M, Bizzarri N, Fruscio R, et al. Impact of substage and histologic type in stage Ⅰ ovarian carcinoma survival: a multicenter retrospective observational study[J]. Int J Gynecol Cancer, 2023, 33(1): 42-49. DOI： 10.1136/ijgc-2022-003745.
|
| [22] |
Nasioudis D, Mulugeta-Gordon L, Mcminn E, et al. Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma[J]. Int J Gynecol Cancer, 2021, 31(3): 480-483. DOI： 10.1136/ijgc-2020-001747.
|
| [23] |
Ayhan A, Tunç M, Akll H, et al. Fertility-sparing approach to malignant ovarian germ cell tumors - oncologic and obstetric outocome: a retrospective study[J]. Int J Gynaecol Obstet, 2024, 164(3): 1074-1079. DOI： 10.1002/ijgo.15141.
|
| [24] |
Vasanth A, Patel SM, Arora R, et al. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India[J]. J Gynecol Oncol, 2024, 35(2): e19. DOI： 10.3802/jgo.2024.35.e19.
|
| [25] |
|
| [26] |
Wang D, Jia C, Cheng H, et al. Analysis of outcomes and prognostic factors after fertility-sparing surgery in patients with early stage juvenile granulosa cell tumor of the ovary: experience from a tertiary center[J]. J Pediatr Adolesc Gynecol, 2022, 35(4): 486-491. DOI： 10.1016/j.jpag.2021.12.005.
|
| [27] |
Johansen G, Lampic C, Flöter Rådestad A, et al. Health-related quality of life, sexual function, psychological health, reproductive concerns and fertility outcome in young women treated with fertility-sparing surgery for ovarian tumors - A prospective longitudinal multicentre study[J]. Gynecol Oncol, 2024, 189(10): 101-108. DOI： 10.1016/j.ygyno.2024.07.004.
|
| [28] |
Marino G, Grassi T, De Ponti E, et al. Fertility outcomes in stage Ⅰ ovarian immature teratomas[J]. Int J Gynecol Cancer, 2024, 34(9): 1416-1422. DOI： 10.1136/ijgc-2024-005534.
|
| [29] |
Mcbain R, Kashyap A, Bishop M, et al. Borderline tumours of the ovary: a 37-year experience at a tertiary referral centre[J]. Aust N Z J Obstet Gynaecol, 2025, 65(1): 163-172. DOI： 10.1111/ajo.13876.
|
| [30] |
Cacciottola L, Camboni A, Gatti E, et al. Fertility potential and safety assessment of residual ovarian cortex in young women diagnosed with epithelial borderline and early-stage malignant ovarian tumors[J]. Gynecol Oncol, 2024, 183: 15-24. DOI: 10.1016/j.ygyno.2024.03.008.
|
| [31] |
Cosyns S, Van Moer E, De Quick I, et al. Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors[J]. Arch Gynecol Obstet, 2024, 309(5): 2143-2152. DOI: 10.1007/s00404-024-07445-x.
|
| [32] |
Bunyaeva E, Kirillova A, Khabas G, et al. Feasibility of in vitro maturation of oocytes collected from patients with malignant ovarian tumors undergoing fertility preservation[J]. Int J Gynecol Cancer, 2021, 31(3): 475-479. DOI： 10.1136/ijgc-2020-001754.
|